Get started
Bristol-Myers Squibb CompanyBristol-Myers Squibb CompanyBristol-Myers Squibb Company

Bristol-Myers Squibb Company

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with Bristol-Myers Squibb Company



Key stats


Market capitalization
‪132.45 B‬ USD
Dividend yield (indicated)
3.89%
Price to earnings Ratio (TTM)
14.28
Basic EPS (TTM)
4.55 USD
Net income (FY)
‪7.05 B‬ USD
Revenue (FY)
‪48.19 B‬ USD
Shares float
‪2.04 B‬
Beta (1Y)
0.20

Latest earnings


Last report date
Jul 30, 2026
Report period
Q2 2026
EPS
2.04 USD
Revenue
‪12.97 B‬ USD
Earnings call summary

Q2 2026 saw 5% revenue growth to $13B, with the growth portfolio up 14% and ELIQUIS up 21%. Full-year guidance for revenue and EPS was raised, supported by strong product performance and a robust pipeline with multiple pivotal readouts expected by year-end.

Employees


Employees (FY)
‪32.5 K‬
Change (1Y)
‪−1.6 K‬−4.69%
Revenue / Employee (1Y)
‪1.48 M‬ USD
Net income / Employee (1Y)
‪217.05 K‬ USD

Details


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Christopher S. Boerner
Website
bms.com
Headquarters
Princeton
Founded
1933
IPO date
Jul 5, 1929
ISIN
US1101221083
CUSIP
110122108
FIGI
BBG000DQLV23
Identifiers
ISIN US1101221083
CFI code
ESVUFR
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


6.628% YTM
Maturity dateAug 1, 2097
Coupon6.88% (Fixed)
6.510% YTM
Maturity dateAug 15, 2043
Coupon5.25% (Fixed)
6.429% YTM
Maturity dateNov 15, 2047
Coupon4.35% (Fixed)
6.388% YTM
Maturity dateFeb 20, 2048
Coupon4.55% (Fixed)
6.133% YTM
Maturity dateMay 15, 2044
Coupon4.63% (Fixed)
6.127% YTM
Maturity dateNov 15, 2053
Coupon6.25% (Fixed)
6.118% YTM
Maturity dateMar 15, 2062
Coupon3.90% (Fixed)
6.096% YTM
Maturity dateNov 13, 2050
Coupon2.55% (Fixed)
6.092% YTM
Maturity dateOct 26, 2049
Coupon4.25% (Fixed)
6.092% YTM
Maturity dateNov 15, 2063
Coupon6.40% (Fixed)
6.085% YTM
Maturity dateMar 15, 2052
Coupon3.70% (Fixed)

See all BMY bonds 

ETFs holding the stock


VTI
Vanguard Morningstar Total Stock Market ETF
Weight0.16%
Market value‪3.74 B‬
SCHD
Schwab US Dividend Equity ETF
Weight3.29%
Market value‪3.53 B‬
VOO
Vanguard S&P 500 ETF
Weight0.18%
Market value‪3.06 B‬
IVV
iShares Core S&P 500 ETF
Weight0.20%
Market value‪1.79 B‬
SPY
SPDR S&P 500 ETF TRUST
Weight0.20%
Market value‪1.62 B‬
VTV
Vanguard Morningstar Value ETF
Weight0.44%
Market value‪1.12 B‬
XLV
State Street Health Care Select Sector SPDR ETF
Weight2.18%
Market value‪959.08 M‬
JEPI
JPMorgan Equity Premium Income ETF
Weight1.18%
Market value‪472.18 M‬
VYM
Vanguard High Dividend Yield ETF
Weight0.49%
Market value‪469.67 M‬
COWZ
Pacer US Cash Cows 100 ETF
Weight2.07%
Market value‪405.39 M‬
HDV
iShares Core High Dividend ETF
Weight2.66%
Market value‪396.38 M‬

Explore more ETFs 

Frequently asked questions


The current price of BMY is 63.61 USD — it has decreased by −1.90% in the past 24 hours. Watch Bristol-Myers Squibb Company stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Bristol-Myers Squibb Company stocks are traded under the ticker BMY.
BMY stock has fallen by −1.97% compared to the previous week, the month change is a 10.07% rise, over the last year Bristol-Myers Squibb Company has showed a 38.16% increase.
We've gathered analysts' opinions on Bristol-Myers Squibb Company future price: according to them, BMY price has a max estimate of 80.00 USD and a min estimate of 40.00 USD. Watch BMY chart and read a more detailed Bristol-Myers Squibb Company stock forecast: see what analysts think of Bristol-Myers Squibb Company and suggest that you do with its stocks.
BMY reached its all-time high on Dec 1, 2022 with the price of 81.44 USD, and its all-time low was 0.91 USD and was reached on Oct 4, 1974. View more price dynamics on BMY chart.
See other stocks reaching their highest and lowest prices.
BMY stock is 2.33% volatile and has beta coefficient of 0.20. Track Bristol-Myers Squibb Company stock price on the chart and check out the list of the most volatile stocks — is Bristol-Myers Squibb Company there?
Today Bristol-Myers Squibb Company has the market capitalization of ‪132.45 B‬, it has increased by 4.67% over the last week.
Yes, you can track Bristol-Myers Squibb Company financials in yearly and quarterly reports right on TradingView.
Bristol-Myers Squibb Company is going to release the next earnings report on Oct 29, 2026. Keep track of upcoming events with our Earnings Calendar.
BMY earnings for the last quarter are 2.04 USD per share, whereas the estimation was 1.60 USD resulting in a 27.73% surprise. The estimated earnings for the next quarter are 1.72 USD per share. See more details about Bristol-Myers Squibb Company earnings.
Bristol-Myers Squibb Company revenue for the last quarter amounts to ‪12.97 B‬ USD, despite the estimated figure of ‪11.74 B‬ USD. In the next quarter, revenue is expected to reach ‪12.59 B‬ USD.
BMY net income for the last quarter is ‪3.32 B‬ USD, while the quarter before that showed ‪2.68 B‬ USD of net income which accounts for 0.00% change. Track more Bristol-Myers Squibb Company financial stats to get the full picture.
Yes, BMY dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (TTM)% is 3.87%. Tracking Bristol-Myers Squibb Company dividends might help you take more informed decisions.
As of Aug 11, 2026, the company has ‪32.5 K‬ employees. See our rating of the largest employees — is Bristol-Myers Squibb Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bristol-Myers Squibb Company EBITDA is ‪19.20 B‬ USD, and current EBITDA margin is 39.92%. See more stats in Bristol-Myers Squibb Company financial statements.
Like other stocks, BMY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bristol-Myers Squibb Company stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bristol-Myers Squibb Company technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bristol-Myers Squibb Company stock shows the buy signal. See more of Bristol-Myers Squibb Company technicals for a more comprehensive analysis.